- Sonoma Shares of Pharmaceuticals jumped 44% on Friday after the company unveiled a product that could replace IV bags for some surgeries.
- The company said the treatment was for abdominal, laparoscopic, orthopedics and periprosthetics.
- Sonoma expects the product to be available this year in Europe and next year in the United States
Shares of Sonoma Pharmaceuticals (SNOA) soared 44% on Friday after the health-care company introduced a new app for pulsed-wash irrigation treatment to the European Union (EU). intraoperative that could replace traditional IV bags for a range of surgical procedures.
Sonoma said they developed this new application to fill an unmet need for “a non-toxic irrigation solution capable of preventing infection and improving healing time” of wounds.
He noted that the Intraoperative Pulse Wash Container is designed to work with a “flush gun” for abdominal, laparoscopic, orthopedic, and periprosthetic operations.
The company said the product was made “in close collaboration with the medical community and Sonoma's existing distribution partners in Europe.” CEO Amy Trombly added that the company continues to see “increased demand for our wound care products in Europe.”
Sonoma reported that it was already accepting orders for the pulse wash irrigation treatment solution, which is expected to be ready for commercial use in Europe in September. It is planning a US launch next year.
Friday earnings contributed to push Sonoma Pharmaceuticals shares into positive territory for the year.
Do you have any news tip for Investopedia reporters? Please email us at email@example.com